Cite
HARVARD Citation
Melero, I. et al. (n.d.). 315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody. Journal for immunotherapy of cancer. p. A341. [Online].